Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholangiocarcinoma: novel therapeutic targets
Keisaku Sato, Shannon Glaser, Domenico Alvaro, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 4, pp. 345-357
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The Tumor Microenvironment in Cholangiocarcinoma Progression
Luca Fabris, Keisaku Sato, Gianfranco Alpini, et al.
Hepatology (2020) Vol. 73, Iss. S1, pp. 75-85
Open Access | Times Cited: 150
miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5
Jingbang Wu, Beng Yang, Yanpeng Zhang, et al.
International Journal of Biological Sciences (2019) Vol. 15, Iss. 8, pp. 1591-1599
Open Access | Times Cited: 63
Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma
Keisaku Sato, Wenjun Zhang, Samira Safarikia, et al.
Hepatology (2020) Vol. 74, Iss. 1, pp. 491-502
Open Access | Times Cited: 53
Noncoding RNA in Cholangiocarcinoma
Massimiliano Salati, Chiara Braconi
Seminars in Liver Disease (2018) Vol. 39, Iss. 01, pp. 013-025
Open Access | Times Cited: 49
Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models
Qingfan Zheng, Bin Zhang, Changfeng Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
Role of miRNA‑122 in cancer (Review)
Jing Zhang, Linghua Wu, Rong Ding, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 4
The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15563-15563
Open Access | Times Cited: 10
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
MicroRNA‐329‐mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma
Zhigao Hu, Chao‐Wen Zheng, Huizhao Su, et al.
Journal of Cellular Biochemistry (2018) Vol. 120, Iss. 6, pp. 9964-9978
Closed Access | Times Cited: 32
<p>Up-regulated LncRNA-ATB regulates the growth and metastasis of cholangiocarcinoma via miR-200c signals</p>
Hai Lin, Lili Yang, Feng Tian, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 7561-7571
Open Access | Times Cited: 25
The Emerging Roles of LINC00665 in Human Cancers
Jing Zhu, Yirao Zhang, Xuyu Chen, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12
Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase
Khac Cuong Bui, Mai Ly Thi Nguyen, Samarpita Barat, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 28, pp. 4534-4548
Closed Access | Times Cited: 2
Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines
Abdulkadir Isidan, Ali Yenigun, Daiki Soma, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 9, pp. 1200-1217
Open Access | Times Cited: 11
Lanatoside C decelerates proliferation and induces apoptosis through inhibition of STAT3 and ROS-mediated mitochondrial membrane potential transformation in cholangiocarcinoma
Chao Zhang, Hongying Yang, Long Gao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM2
Yusen Zhang, Liping Liu, Biwei Luo, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 3, pp. 317-331
Open Access | Times Cited: 5
Suppressive effects of umbilical cord mesenchymal stem cell-derived exosomal miR-15a-5p on the progression of cholangiocarcinoma by inhibiting CHEK1 expression
Nuo Li, Baoming Wang
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Exosome-transmitted miR-3124-5p promotes cholangiocarcinoma development via targeting GDF11
Huijie Gao, Zhaobin He, Chao Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Unraveling the heterogeneity of cholangiocarcinoma and identifying biomarkers and therapeutic strategies with single-cell sequencing technology
Wangyang Chen, Dongchao Xu, Qiang Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114697-114697
Open Access | Times Cited: 4
Targeting polycomb repressor complex 2‐mediated bivalent promoter epigenetic silencing of secreted frizzled‐related protein 1 inhibits cholangiocarcinoma progression
Guanhua Wu, Qi Wang, Da Wang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 4
Current Advances in Basic and Translational Research of Cholangiocarcinoma
Keisaku Sato, Leonardo Baiocchi, Lindsey Kennedy, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3307-3307
Open Access | Times Cited: 10
A universal co‐expression gene network and prognostic model for hepatic–biliary–pancreatic cancers identified by integrative analyses
Jing Zhang, Juan Xiao, Yixuan Wang, et al.
FEBS Open Bio (2022) Vol. 12, Iss. 11, pp. 2006-2024
Open Access | Times Cited: 7
RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination
Chengshuo Zhang, Yu Wang, Gang Wu, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Arsenic trioxide enhances the chemotherapeutic efficiency of cisplatin in cholangiocarcinoma cells via inhibiting the 14-3-3ε-mediated survival mechanism
Ming Jin, Liunan Wu, Shuai Chen, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Treating Biliary Tract Cancers: New Targets and Therapies
Joseph K. Ho, Constance Fiocco, Kristen Spencer
Drugs (2022) Vol. 82, Iss. 17, pp. 1629-1647
Closed Access | Times Cited: 6
The role of extracellular vesicles in cholangiocarcinoma
Mingzhen Bai, Wenkang Fu, Gang Su, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top